Metraipolis › archive › dc_eaf366fd3041

Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind,… — Europe PMC PMID:41012176

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41012176
DOI: 10.3390/vaccines13090973
License (as archived): solo-consultazione
Archived: 2026-11-09T23:34:28.692Z
SHA-256 of the archived text: fb1541cc65fe4d390c6af4f5dbb2b6486f6cd741b3e85306172d53e6598b077d
Stable URL of this page: https://metraipolis.com/documento/dc_eaf366fd3041

How to cite

Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind,… — Europe PMC PMID:41012176 — Europe PMC (en), https://europepmc.org/article/MED/41012176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eaf366fd3041 (Metraipolis archive dc_eaf366fd3041, sha256 fb1541cc65fe4d390c6af4f5dbb2b6486f6cd741b3e85306172d53e6598b077d)

BibTeX

@misc{dceaf366fd3041,
  title = {Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Healthy Children Aged 12 to 15 Months: A Phase III, Randomized, Double-Blind,… — Europe PMC PMID:41012176},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012176},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eaf366fd3041; sha256 fb1541cc65fe4d390c6af4f5dbb2b6486f6cd741b3e85306172d53e6598b077d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012176. Agents can read the archived copy with the MCP tool read_document.